These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31047049)

  • 1. Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel.
    Yan C; Liang N; Li Q; Yan P; Sun S
    Carbohydr Polym; 2019 Jul; 216():129-139. PubMed ID: 31047049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
    Baek JS; Kim JH; Park JS; Cho CW
    Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.
    Yuan H; Gui H; Chen S; Zhu L; Wang C; Jing Q; Lv H; Wan Q; Wang S; Zhou S; Ren X; Nie Y; Li L
    Int J Nanomedicine; 2024; 19():3589-3605. PubMed ID: 38645464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxypropyl-β-cyclodextrin-graphene oxide conjugates: Carriers for anti-cancer drugs.
    Tan J; Meng N; Fan Y; Su Y; Zhang M; Xiao Y; Zhou N
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():681-7. PubMed ID: 26838897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-β-cyclodextrin for oral insulin delivery.
    Li S; Liang N; Yan P; Kawashima Y; Sun S
    Carbohydr Polym; 2021 Jan; 252():117202. PubMed ID: 33183638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy.
    Shen Q; Shen Y; Jin F; Du YZ; Ying XY
    J Liposome Res; 2020 Mar; 30(1):12-20. PubMed ID: 30741058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles.
    Li F; Wen Y; Zhang Y; Zheng K; Ban J; Xie Q; Wen Y; Liu Q; Chen F; Mo Z; Liu L; Chen Y; Lu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4097-4108. PubMed ID: 31663388
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
    Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
    J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Targeting and pH-Sensitive Inclusion Complex Based on HP-β-CD as a Potential Carrier for Paclitaxel: Fabrication, Molecular Docking, and Characterization.
    Li Z; Zhao W; Liang N; Yan P; Sun S
    Biomacromolecules; 2023 Jan; 24(1):178-189. PubMed ID: 36538015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
    Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
    J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
    Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
    Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.